Newbury Pharmaceuticals AB

Research Newbury Pharmaceuticals AB (NEWBRY) on Bullrun: market cap SEK 67.48M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerNEWBRY
ExchangeST
CountrySweden
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencySEK
Market capSEK 67.48M
Financial periodQ3 2026
RevenueSEK 9.37M
Net income-SEK 5.01M
Gross margin39.2%

Valuation Snapshot

latest market cap is SEK 67.48M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	SEK 38.04M	-SEK 21.54M	n/a	39.0%	n/a	SEK 7.92M	n/a	SEK 35.85M
FY2024	SEK 24.61M	-SEK 21.78M	n/a	49.9%	n/a	SEK 19.43M	n/a	SEK 46.77M
FY2023	SEK 11.17M	-SEK 19.42M	n/a	43.5%	n/a	SEK 8.53M	n/a	n/a
FY2022	SEK 7.23M	-SEK 14.68M	n/a	45.4%	n/a	SEK 33.33M	n/a	n/a

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-03	SEK 67.48M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About Newbury Pharmaceuticals AB

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

BioGaia AB (publ) (BIOG-B) Cinclus Pharma (CINPHA) Cereno Scientific AB Series B (CRNO-B) Dicot AB (DICOT) Enzymatica publ AB (ENZY) EQL Pharma (EQL.ST) Enorama Pharma AB (ERMA) Gabather AB (publ) (GABA) Klaria Pharma Holding (KLAR.ST) Moberg Pharma (MOB.ST) Nanexa AB (NANEXA) ODI Pharma AB (publ) (ODI.ST)

Frequently asked questions

What is Newbury Pharmaceuticals AB's market cap?

Newbury Pharmaceuticals AB's market capitalization is SEK 67.48M.